Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Apoptosis : an international journal on programmed cell death | journal | 1.521 Q1 | 128 | 111 | 406 | 5963 | 1667 | 401 | 4.04 | 53.72 |  |
| 52 | Toxicology and Applied Pharmacology | journal | 1.496 Q1 | 189 | 282 | 952 | 15536 | 4272 | 949 | 4.11 | 55.09 |  |
| 53 | Topics in antiviral medicine | journal | 1.493 Q1 | 46 | 17 | 58 | 356 | 216 | 55 | 3.21 | 20.94 | |
| 54 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 141 | 416 | 11331 | 1366 | 386 | 3.31 | 80.36 |  |
| 55 | Drug Metabolism and Disposition | journal | 1.466 Q1 | 194 | 217 | 713 | 9295 | 2946 | 706 | 4.26 | 42.83 | |
| 56 | Vaccines | journal | 1.457 Q1 | 85 | 48 | 95 | 4565 | 385 | 92 | 4.08 | 95.10 |  |
| 57 | Drug Safety | journal | 1.454 Q1 | 140 | 105 | 313 | 5877 | 1117 | 270 | 3.47 | 55.97 | |
| 58 | Therapeutic Advances in Neurological Disorders | journal | 1.442 Q1 | 68 | 47 | 86 | 2043 | 394 | 82 | 4.87 | 43.47 | |
| 59 | Current Neuropharmacology | journal | 1.385 Q1 | 103 | 120 | 169 | 12931 | 723 | 150 | 3.15 | 107.76 |  |
| 60 | Pharmacogenomics Journal | journal | 1.377 Q1 | 95 | 76 | 227 | 3861 | 966 | 227 | 3.87 | 50.80 | |
| 61 | Journal of Biomolecular Screening | journal | 1.347 Q1 | 86 | 113 | 391 | 3588 | 1047 | 388 | 2.55 | 31.75 | |
| 62 | Prostaglandins and Other Lipid Mediators | journal | 1.341 Q1 | 86 | 46 | 148 | 2674 | 458 | 142 | 2.71 | 58.13 | |
| 63 | Investigational New Drugs | journal | 1.340 Q1 | 97 | 89 | 457 | 2942 | 1606 | 455 | 3.71 | 33.06 | |
| 64 | European Journal of Medicinal Chemistry | journal | 1.289 Q1 | 203 | 720 | 2376 | 36217 | 11145 | 2371 | 4.81 | 50.30 |  |
| 65 | Experimental and Clinical Psychopharmacology | journal | 1.275 Q1 | 101 | 47 | 170 | 3081 | 431 | 167 | 2.45 | 65.55 | |
| 66 | Current Cancer Drug Targets | journal | 1.271 Q1 | 103 | 84 | 221 | 7769 | 816 | 205 | 2.78 | 92.49 | |
| 67 | Acta Pharmacologica Sinica | journal | 1.250 Q1 | 117 | 163 | 509 | 7570 | 1834 | 503 | 3.02 | 46.44 | |
| 68 | Antiviral Therapy | journal | 1.247 Q1 | 93 | 96 | 349 | 2850 | 877 | 339 | 2.34 | 29.69 | |
| 69 | Vascular Pharmacology | journal | 1.247 Q1 | 108 | 126 | 261 | 7703 | 923 | 252 | 3.68 | 61.13 | |
| 70 | Expert Opinion on Investigational Drugs | journal | 1.210 Q1 | 117 | 126 | 411 | 11124 | 1545 | 405 | 3.80 | 88.29 | |
| 71 | Pharmacogenomics and Personalized Medicine | journal | 1.208 Q1 | 37 | 15 | 67 | 912 | 289 | 67 | 4.76 | 60.80 |  |
| 72 | Pharmacology Biochemistry and Behavior | journal | 1.206 Q1 | 148 | 115 | 721 | 6419 | 2229 | 715 | 3.20 | 55.82 | |
| 73 | Cancer Chemotherapy and Pharmacology | journal | 1.204 Q1 | 122 | 276 | 884 | 9340 | 2810 | 873 | 2.96 | 33.84 |  |
| 74 | Journal of Natural Products | journal | 1.202 Q1 | 161 | 400 | 1112 | 14257 | 4023 | 1105 | 3.46 | 35.64 | |
| 75 | Clinical Therapeutics | journal | 1.190 Q1 | 150 | 249 | 705 | 9196 | 2052 | 613 | 2.75 | 36.93 | |
| 76 | Cancer Biology and Therapy | journal | 1.181 Q1 | 130 | 144 | 553 | 5905 | 1738 | 522 | 3.16 | 41.01 | |
| 77 | Current Drug Targets | journal | 1.172 Q1 | 119 | 241 | 469 | 26140 | 1431 | 426 | 2.58 | 108.46 | |
| 78 | Expert Opinion on Biological Therapy | journal | 1.167 Q1 | 102 | 139 | 502 | 11318 | 1752 | 489 | 3.43 | 81.42 | |
| 79 | ChemMedChem | journal | 1.156 | 119 | 320 | 780 | 13373 | 2163 | 771 | 2.80 | 41.79 | |
| 80 | Pharmacognosy Reviews (discontinued) | journal | 1.140 Q1 | 68 | 20 | 68 | 1475 | 314 | 67 | 4.72 | 73.75 |  |
| 81 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.127 Q1 | 57 | 59 | 184 | 2833 | 510 | 179 | 2.95 | 48.02 | |
| 82 | Pharmaceutical Research | journal | 1.112 Q1 | 229 | 241 | 853 | 11327 | 3303 | 843 | 3.57 | 47.00 | |
| 83 | European Journal of Clinical Pharmacology | journal | 1.098 Q1 | 123 | 179 | 633 | 5787 | 1828 | 563 | 2.95 | 32.33 | |
| 84 | Cardiovascular Therapeutics | journal | 1.095 Q1 | 54 | 58 | 168 | 2165 | 424 | 161 | 2.53 | 37.33 | |
| 85 | Phytomedicine | journal | 1.094 Q2 | 141 | 199 | 587 | 8722 | 2296 | 573 | 3.91 | 43.83 | |
| 86 | Current Molecular Pharmacology | journal | 1.090 Q2 | 49 | 37 | 73 | 3579 | 167 | 62 | 2.19 | 96.73 | |
| 87 | European Journal of Pharmacology | journal | 1.090 Q2 | 203 | 588 | 2069 | 31023 | 6547 | 2060 | 3.12 | 52.76 | |
| 88 | International Immunopharmacology | journal | 1.088 Q2 | 149 | 407 | 1214 | 18308 | 3998 | 1202 | 3.23 | 44.98 | |
| 89 | Journal of Ethnopharmacology | journal | 1.087 Q2 | 231 | 692 | 2021 | 39403 | 7504 | 2009 | 3.44 | 56.94 |  |
| 90 | Current Medicinal Chemistry | journal | 1.085 Q2 | 202 | 276 | 956 | 36282 | 3493 | 901 | 3.39 | 131.46 | |
| 91 | Current Pharmaceutical Design | journal | 1.069 Q2 | 183 | 581 | 1906 | 75638 | 5822 | 1740 | 2.73 | 130.19 | |
| 92 | Cardiovascular Drugs and Therapy | journal | 1.067 Q2 | 79 | 66 | 207 | 3398 | 560 | 170 | 2.54 | 51.48 | |
| 93 | Expert Opinion on Therapeutic Patents | journal | 1.057 Q2 | 88 | 110 | 328 | 9821 | 1305 | 325 | 3.16 | 89.28 | |
| 94 | Journal of Clinical Pharmacology | journal | 1.046 Q2 | 130 | 195 | 519 | 7813 | 1484 | 491 | 2.76 | 40.07 | |
| 95 | BioDrugs | journal | 1.035 Q2 | 79 | 48 | 139 | 2995 | 476 | 131 | 3.18 | 62.40 | |
| 96 | Inflammation Research | journal | 1.025 Q2 | 107 | 97 | 327 | 4549 | 946 | 324 | 2.82 | 46.90 | |
| 97 | Phytotherapy Research | journal | 1.016 Q2 | 158 | 217 | 775 | 11891 | 2794 | 770 | 3.61 | 54.80 | |
| 98 | Microbial Drug Resistance | journal | 1.015 Q2 | 78 | 96 | 261 | 3569 | 663 | 247 | 2.48 | 37.18 | |
| 99 | Behavioural Pharmacology | journal | 1.014 Q2 | 87 | 92 | 239 | 4945 | 584 | 234 | 2.41 | 53.75 | |
| 100 | Expert Opinion on Pharmacotherapy | journal | 1.014 Q2 | 93 | 238 | 734 | 17781 | 2325 | 715 | 3.40 | 74.71 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data